Professional Documents
Culture Documents
An Overview of Herbal Alternatives in Androgenetic Alopecia
An Overview of Herbal Alternatives in Androgenetic Alopecia
DOI: 10.1111/jocd.12930
REVIEW ARTICLE
KEYWORDS
androgenetic alopecia, conventional drugs, dihydrotestosterone, herbal alternatives,
mechanism of action, side effects
1 | I NTRO D U C TI O N and 65 years.5 The earliest indications of AGA can be observed after
puberty.6 Prevalence statistical data are presented in Table 1.
Androgenetic alopecia (AGA) is a highly common and chronic prob‐ Androgenetic alopecia is generally an androgen hormone‐de‐
lem which is characterized by advancing miniaturization of the hair pendent process in which testosterone is converted into an active
follicles.1,2 The term AGA was coined by Norman Orentreich in androgen dihydrotestosterone (DHT) by enzyme 5‐alpha‐reductase
1960.3 AGA expressly is seen of scalp hair having distinct patterns (Figure 1). DHT binds to androgen receptors present in the hair fol‐
of hair loss in both genders most commonly the central scalp and licles triggering a process diminishing the anagen phase and over a
1
habitually initiates around puberty. AGA can be capable of affecting period of time the terminal hair converts into a thinner and shorter
4
all races. The highest prevalence is observed in Caucasians. AGA is vellus hair. The probability of AGA increases with aging.6 The aim
also known as male pattern hair loss (MPHL) and female pattern hair of this review article was to provide a brief introduction about
1
loss (FPHL). The highest prevalence is observed in ages between 30 the herbal remedies which have potential to replace conventional
TA B L E 1 Study of prevalence of population affected by relatively due to the vehicles such as ethyl alcohol and propylene
androgenetic alopecia (AGA)2,4 glycol used in its dosage form used at high concentration.11 Similarly,
Affected with AGA for Finasteride oral treatment have been found to show adverse ef‐
fects.9,12 All the side effects and adverse reactions are presented in
Population Men Women Study
Table 3.
Caucasians 80% 40‐50% Kelly Y et al (2016)2 Current research on drugs mentioned in Table 4 focuses on
Asian 58% overall Kaliyadan F et al reduction of the active concentrations by using their combina‐
(2013) 4 tions and transforming them into novel dosage forms for topical
Chinese 21.3% 6.0% Kaliyadan F et al use. Minoxidil, a FDA approved drug, has been tested for a wide
(2013) 4
range of concentrations. A conventional solution of 5% was found
African 14.6% 3.5% Kelly Y et al (2016)2 to be more effective than a 2% conventional solution. Currently,
Kean 14.1% 5.6% Kaliyadan F et al reported literature proves the efficacy of a 2% solution in a novel
(2013) 4
carrier system.13,14 Similarly finasteride, another FDA approved
drug, has been reported effective in 0.25% and 0.5% topical solu‐
therapies. AGA needs long‐term treatment, and there are side ef‐ tion compared to an oral 1 mg/d dose.14,15 Other treatments such
fects and toxicities associated with the conventional FDA approved as low‐laser therapy, microneedling in scalp, hair mesotherapy,
drugs. Herbal sources can provide beneficial treatment along with, and hair transplantation are alternative treatments. Janus kinase
minimum side effects when compared to the conventional marketed and use of platelet‐rich plasma are in research; however, there is
drugs. The pathogenesis of normal hair cycle (A) and the hormone‐ limited information available and use in AGA.14 MorrF, a combina‐
affected cycle (B) is presented in Figure 2. tion of minoxidil 5% solution and Finasteride 0.1% lipid solution,
is used for alopecia.12
Following Table 5 represents few clinical trial studies that are
2 | M E TH O DS ongoing, completed, and terminated.
Following are the herbal sources that can be potentially used fin
A methodical literature review was executed. Study exploration the treatment of AGA.
was conducted using online databases—PubMed and Science Direct
using keywords Androgenetic, Alopecia, Hair Loss, Saw Palmetto, 1. Saw palmetto (S repens)
Serenoa repens, Curcurbita pepo, Rosemary, Green Tea, Minoxidil, 2. Green tea (C sinensis)
Finasteride, Pumpkin Seed, Camellia sinensis, Glycyrrhiza glabra, 3. Pumpkin seed (C pepo)
Onion, Garlic, Grape seed, etc Literature focuses on the alternatives 4. Rosemary (Rosmarinus officinalis)
to synthetic drugs, case studies, clinical trials, case reports, and com‐ 5. Grape seed (Vitis vinifera)
parison type studies. 6. Licorice (G glabra)
3 | R E S U LT S A N D D I S CU S S I O N
3.1 | Saw palmetto
Androgenetic alopecia requires long‐term treatment therapy. Many Saw palmetto is known as S repens (commonly available), Serenoa ser-
medications are available for hair loss out of which only two are ap‐ rulata, or Sabal serrulata. It is extracted from palm tree berries be‐
proved by FDA for AGA. Minoxidil available in two concentrations a longing to the Arecaceae family inherent to the West Indies, Atlantic
2% which is approved for FPHL and 5% is approved for MPHL topi‐ coast of North America (from South Carolina to Florida). The extract
cal treatment and Finasteride at 1 mg oral medication (Figure 3).8,9 or oil obtained from the berries of saw palmetto is found to be rich
Some of the brands that are prescribed are presented in Table 2. in fatty acids (85%‐90%), other constituents include sterols rich in
Conventional therapy presents many side effects and disad‐ carotenoids, lipases, tannin, sugars and beta sitosterol, anthranilic
vantages due to long‐term treatment. Side effects of Minoxidil are acid, capric acid, caproic acid, caprylic acid, ‐carotene, ferulic acid,
OH OH
H
H
5-alpha-reductase
H H
H H
O
O H
F I G U R E 1 Pathway for conversion of
TESTOSTERONE DHT Dihydrotestosterone testosterone to dihydrotestosterone
DHARIWALA and RAVIKUMAR |
3
O
NH
H
N
H
N N N H H
H O H O N
H
H H
F I G U R E 3 Structure of minoxidil and
finasteride MINOXIDIL FINASTERIDE
mannitol, ‐sitosterol, ‐sitosterol‐d‐glucoside, linoleic acid, myris‐ 5‐alpha‐reductase out of which lauric acid, myristic acid, and oleic
tic acid, lauric acid, oleic acid, palmitic acid, 1‐monolaurin, and acid may be the main fatty acids responsible as saw palmetto is rich
17-19
1‐monomyristin. in them (85%‐90% fatty acids are present).10
It is observed that beta sitosterol and fatty acids (lauric acid, The mechanism of action of saw palmetto is similar to finasteride,
myristic acid, and oleic acid) are responsible for the inhibition of that is, inhibition of 5‐alpha‐reductase which converts testosterone
|
4 DHARIWALA and RAVIKUMAR
TA B L E 3 Limitations of long‐term
Side effects and adverse reactions
treatment of androgenetic alopecia
Minoxidil Finasteride Study
to DHT responsible for AGA.10,20,21 Dose 320 mg/d10,20 was found bronchitis), asthma, chest congestion, thyroid disorders, di‐
to be effective. gestion and absorption of nutrients, and polycystic ovary
Other uses of saw palmetto include the following: Baldness, syndrome.10,17,20
benign prostatic hyperplasia (BPH), in strengthening and build‐ It can be observed that the side effects associated with finas‐
ing tissues, increasing metabolism (stimulates appetite), diuretic teride can be avoided with the use of herbal remedy like S repens
which improves urinary flow, expectorant (relieve chronic (Figure 4). 22
DHARIWALA and RAVIKUMAR |
5
Nonscarring alopecia's
Androgenic alopecia 1. Minoxidil 1. 2% or 5% 1. Rogaine 1. Topical
2. Finasteride 2. 1 mg 2. Propecia 2. Oral
3. Minoxidil & Finasteride 3. Minoxidil 3. Intas pharmaceuticals LTD 3. Topical
[5%]+Finasteride
[0.1%]
Alopecia areata 1. Minoxidil 1. 2% or 5% 1. Rogaine 1. Topical
2. Anthralin 2. 0.5%‐1.0% 2. Dritho‐Scalp 2. Cream
3. Diphenylcyclopropenone 3. 1% 3. Micanol 3. Topical cream
(DPCP)
Telogen effluvium No treatment is necessary after the initial cause is removed; common triggers for telogen effluvium are medications,
illness, childbirth, and crash diets
Trichotillomania Selective serotonin reuptake 1. 25 mg 1. Zoloft 1. Oral
inhibit (SSRI) 2. 25 mg, 80 mg, 2. Luvox 2. Oral
100 mg 3. Sarafem 3. Oral
3. Not to exceed
80 mg/d
Traction alopecia Minoxidil 2% or 5% Rogaine Topical
Tinea capitis Antifungal medications 2% Sandoz Shampoo
Ketoconazole
Sht and loose anagen Minoxidil 2% or 5% Rogaine Topical
syndrome
Tempal alopecia Minoxidil 2% or 5% Rogaine Topical
triangularis
Scarring alopecia's
Lichen planopilaris 1. Hydroxychloroquine 1. 200 mg 1. Plaquenil 1. Oral
Combination of topical, sulphate 2. 10 mg/mL 2. Aristocort 2. Injection
intralesional andal 2. Triamcinolone 3. 25‐40 mg/d 3. Deltasone 3. Oral
therapies 3. Prednisone
Frontal fibrosing Minoxidil 2% or 5% Rogaine Topical
alopecia
Chronic cutaneous Hydroxychloquine sulphate 6.5‐20 mg Plaquenil Topical
lupus erythematosus
Central centrifugal 1. Hydroxychloroquine 1. 6.5‐20 mg 1. Plaquenil 1. Topical
cicatricial alopecia sulphate 2. 300 mg 2. Declomycin 2. Oral
2. Tetracycline
Folliculitis decalvans Tetracycline 300 mg Declomycin Oral
|
6 DHARIWALA and RAVIKUMAR
Completed
NCT03004469 A multicentre, randomized, double‐blind, parallel‐group, Drug: P‐3074 Phase 3
controlled study, to assess the efficacy and safety of
P‐3074 cutaneous spray, solution, in the treatment of
male pattern baldness
NCT02503852 Subcutaneous transplantation of autologous cell enriched PureGraft and celution system Phase 2
adipose tissue ffollicular niche stimulation in early stage
alopecia androgenetica (STYLE): a randomized, blinded,
controlled trial
NCT01286649 Randomized, single‐centre, double‐blind, placebo‐con‐ Human autologous hair follicle cells Phase 1 Phase 2
trolled, Phase I/IIa study to evaluate the safety and
efficacy of human autologous hair follicle dermal sheath
cup cells (DSCC) in women and men with AGA
NCT02503137 A Phase 2, multicenter, randomized, double‐blind study of Topical SM04554 solution Phase 2
SM04554 applied topically to the scalp of male subjects
with AGA analyzed by biopsy of the scalp prito and post
dosing
Ongoing
NCT03742518 Multicenter, randomized, double‐blind, placebo‐con‐ Topical SM04554 solution Phase 3
trolled study of the efficacy and safety of 0.15% &
0.25% concentrations of topical SM04554 solution in
male subjects with androgenetic
NCT03676400 Clinical study for the assessment of the hair growth Conditioned media of umbilical cd Not applicable
efficacy and safety of a cosmetic investigational blood‐derived stem cells
product, after repeated applications for 24 wk, under
normal conditions of use, in the Asian adult subjects
with androgenic alopecia
NCT03388840 The effect of adipose derived stem cells combined with Adipose‐derived stem cells Phase 4
platelet rich plasma vs platelet rich plasma alone on suspension
follicular unit extraction hair transplantation in male
androgenic alopecia: clinical trial
NCT03723369 The effect of microneedling with low energy laser in Acupuncture Not applicable
androgenic alopecia patients
Terminated
NCT02676310 Dose escalation study of the safety, tolerability, and Bimatoprost Phase 1
pharmacokinetics of bimatoprost topical solution in the
treatment of AGA in men
NCT01292746 An evaluation of the effect of the Erchonia Ml scanner Erchonia MLS Not applicable
(MLS) on the treatment of androgenic alopecia in
females
OH
OH
OLEIC ACID
HO
OH
OH
O OH
OH
H
O
H
PHYTOSTEROLS
OH
H
HO O H
HO
OH
F I G U R E 6 Structure of phytosterols
OH
3.4 | Rosemary
3.3 | Pumpkin seed
Rosemary biological name R officinalis family Labiatae is grown
Pumpkin seed or C pepo, locally known as “Kadoo” in Indian na‐ widely around the world along the sub‐Himalayan areas, having cul‐
tive languages while in English “Squash,” belongs to family tivations since ancient days in England, Germany, France, Denmark,
Cucurbitaceae. 28 Pumpkin seed origin is from Central and South America, Venezuela, Philippines, and the northern and southern
America but it also cultivated in Tropical Asia. 25,26 Curcurbita pepo coasts of the Mediterranean sea.33 Its fresh leaves and flowering
is the most common species whereas Cucurbita maxima are the buds contain rosmarinic acid, caffeic acid, chlorogenic acid, carnosic
second most common pumpkin species. The chemical constitu‐ acid, rosmanol, carnosol, and different diterpenes and many other
ents also vary species to species but it was found that the yield of natural antioxidants, ursolic acid, glycolic acid, and rosmaricine. The
fatty acids, sterols or phytoestrogens and tocopherols remained rosemary oil contains esters (2%‐6%) largely as borneol, cineoles,
the major three components of pumpkin seeds. Conversely, com‐ and several terpenes, chiefly a‐pinene, camphene, 1%‐2% volatile oil
ponents present in minor‐ protein, mineral, terpenic alcohol, and containing 0.8%‐6% of esters and 8%‐20% of alcohols.19,33
fiber gave a synergistic effect to the major components and could Caffeic acid, 1, 8‐cineole, and rosmarinic acid are potential ther‐
not be neglected. Curcurbita pepo is rich in polyunsaturated fatty apeutic agents obtained in rosemary oil by steam distillation.19,33 It
acids about 80%‐ palmitic acid, myristic acid, stearic acid, oleic was observed that when compared to Minoxidil, Rosemary results
acid, and linoleic acid, vitamin E like α‐tocopherols, γ‐tocophe‐ did not show a significant difference from the results obtained of
rols and carotenoid, phytoestrogens, and phytosterols and trace Minoxidil.34 Rosemary acts by improving blood circulation and im‐
29,30
components. proving vascularity helping the regeneration of follicles similar effect
In a study by Schiebel‐Schlosser and Friederich, it was observed that is provided by Minoxidil.33,34
that BPH patients when treated with capsules containing 500 mg of Other uses of Rosemary are antidepressant activity, antitumor
pumpkin seed extract there were no side effects. 29 In another study genic effect, choleretic and hepatoprotective effects, antimycotic
by Young Hye Cho et al, volunteers for a period of 12 months 320 mg activity, treatment for alopecia areata, treatment of dermatological
of pumpkin seed oil dose were tested which showed improvement disorders, anti‐inflammatory action, spasmolytic activity on smooth
than compared with placebo. It is observed that the combination of muscles helping relaxation, and antioxidant activity (Figure 7).33,34
31
pumpkin seed and saw palmetto can be beneficial.
Pumpkin seed oil and extract has been reported to inhibit 5‐
3.5 | Grape seed
alpha‐reductase activity with a dose of 400 mg/d for 24 weeks. This
action is suggested due to phytosterols, also the presence of lipids Grape seed or V vinifera berries of which belong to family Vitaceae35
10,32
can be a factor that adds synergistic effect for treatment of AGA. are grown widely in Russia, Europe, Iran, Afghanistan, and in India
Other uses of pumpkin seed:‐ arthritis, antitumor effect, ther‐ having presence of anthocyanins, flavan‐3‐ols (ie, catechins), vita‐
apy for irritable bladder, hypertension, hypercholesterolemia, anti‐ min E (α‐tocopherol), petiole, linoleic acid, flavonoids (resveratrol,
oxidant and anti‐inflammatory, benign prostate hyperplasia, bladder quercetin and catechin, and polyphenols (flavonoids, phenolic acids,
stone disease, alleviated diabetes, abdominal cramps, antiestrogenic, phenolic alcohols, stilbenes, and lignans), procyanidins (B4 and B6),
anti‐oxidative, antiviral, antibacterial, insecticidal or fungistatic, and trimer gallate, unsaturated fatty acids, and phytosterols in which
|
8 DHARIWALA and RAVIKUMAR
OH
OH
Caffeic Acid
O
O OH
HO
O O
H
H
H
H
CH3
CH3 HO
HO
CH3 OH
F I G U R E 7 Structure of caffeic acid,
OH 1,8-CINEOLE ROSMARINIC ACID
1,8‐cineole and rosmarinic acid
OH
as follows:‐ activity in various cancer therapy lung cancer, colon
cancer, bladder cancer, breast cancer, prostate cancer, pancreatic
HO O
cancer, head and neck squamous, cervical cancer, colorectal cancer,
skin cancer, oral cancer, intestinal tumorigenesis, antioxidant, anti‐
inflammatory effect, antimicrobial activity, scavenging activity, anti‐
OH mutagenic activity, antitumor‐promoting effects, antifungal activity,
OH antiulcer activity, capillary protective action, anti‐hypertensive ef‐
OH fect, and hair‐growing activity (Figure 8).35-37
OH
3.6 | Licorice
HO O
Licorice is obtained from root or stem of G glabra belonging to fam‐
ily Leguminosae and is well known traditionally and widely availa‐
OH ble flavoring herb. 38,39 Glycyrrhiza glabra is known as Yashtimadhu,
OH n Sweet wood (English). 39 It is used widely in all countries of the
OH world with wide cultivation in India (Jammu and Kashmir, Punjab,
OH and Sub‐Himalayan).40 Its constituents include glycyrrhizin which
is a 60 times sweeter than sugar cane, glycyrrhizic, and glycyr‐
HO O rhetinic acids, rich in flavonoids such as liquiritin, isoliquiritin,
neoisoliquiritin, liquiritigenin, isoliquiritigenin, rhamnoliquiritin,
glabrine, glabranine, formononetin, licuraside, lichalcones (A and
OH
B), hispaglabridin (A and B), licoricidin, glabrene, pinocembrin,
OH prunetin, saponeretin, 11‐deoxoglycyrrhetic, 24‐hydroxyliquiritic,
OLIGOMERIC PROCYANIDINS: n=0-5 liquiridolic acids, glabrolide, deoxoglabrolide, deoxoglabrolide,
POLYMERIC PROCYANIDINS: n>5
isoglabrolidde, licoflavonol, glycerol, licoricone, glabridin, glabrol,
F I G U R E 8 Structure of procyanidins 7‐acetoxy‐2‐methylisoflavone, 7‐methoxy‐2‐methylisoflavone,
7‐hydroxy‐2‐methylisoflavone, glyzarin, glyzaglabrin, licoisofla‐
catechins, epicatechins, trans‐resveratrol, and procyanidin B1 are vones, glycyrin, sugars, and aspargin. 39,40 The main constituents
19,35,36
the most active and potential ones. are glycyrrhizin, potassium, and calcium salt of glycyrrhizinic
It was found that proanthocyanidins found in grape seed oil and acid.41
extract showed an activity in the proliferation of hair follicle cells iso‐ The extract was identified to have the presence of glycosides,
lated from mice by about 230% relative to controls (100%) also pos‐ terpenoid, phenolics, and flavonoids which were widely available
sessed remarkable hair‐cycle‐converting activity from the telogen having antagonizing testosterone effect. It is seen that phytosterols
phase to the anagen phase in C3H mice in vivo test systems.19,35,37 may be the inhibitor of some steroid dehydrogenases (which could be
DHARIWALA and RAVIKUMAR |
9
O
4 | CO N C LU S I O N
O
O
Androgenetic alopecia is a type of most prevalent alopecia and of
HO
major concern. It occurs majorly due to excess of testosterone get‐
ting converted into DHT via enzyme 5‐alpha‐reductase in the body
HO O
and also can be due to inadequate blood flow in the scalp. Minoxidil
OH OH
O
and finasteride are FDA approved drugs where minoxidil increases
the blood flow and vascularity in the scalp when topically applied
O
and finasteride inhibits the enzyme 5‐alpha‐reductase preventing
OH
the conversion of testosterone to DHT when given orally. Side ef‐
HO OH
fects accompanied with these FDA approved drugs include scalp
F I G U R E 9 Structure of glycyrrhizin dryness, impotence, skin irritation, decreased libido, rashes, erec‐
tile dysfunction, testicular pain, burning, ejaculation disorders, red‐
ness, breast enlargement Or tenderness, erythema, and headache.
5‐alpha‐reductase) that converts testosterone to DHT and thus be the To overcome these side effects, herbal therapy can be a potential
beneficial in treatment of AGA.40 In another study, it was compared treatment. Saw palmetto (S repens), Green tea (C sinensis), Pumpkin
to the standard Minoxidil 2%; it showed better activity in hair growth seed (C pepo), and Licorice (G glabra) are reported to inhibit 5‐alpha‐
when used as a hydro‐alcoholic extract 2% concentration. Therefore, reductase enzyme whereas Rosemary (R officinalis) shows action
it can be said that G glabra has a powerful hair growth activity.40,42 by improving blood circulation to scalp and Grape seed (V vinifera)
Other important uses of G glabra are immunomodulatory activ‐ showed proliferation of hair follicle cells and activity in hair physi‐
ity (glycyrrhetinic acid), antitussive activity (glycyrrhizin), anti‐in‐ ological cycle. Herbal drugs can be more advancing than conven‐
flammatory activity (glycyrrhetic acid, liquiritoside, licochalcone a), tional when used topically on the scalp. More research towards
these herbal drugs using in combinations of two or more together 23. Kokate CK, Purohit A. Pharmacognosy. Pune, India: Nirali Prakashan;
can open new perspective in the cosmetic field which can be safe, 2016.
24. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of
effective, and useful.
green tea: a literature review. Chin Med. 2010;5:1‐9.
25. Jigisha A, Nishant R, Navin K, et al. Green tea: a magical herb with
miraculous outcomes. Int Res J Pharm. 2012;3:139‐148.
ORCID
26. Farooq S, Sehgal A. Antioxidant activity of different forms of green tea:
loose leaf, bagged and matcha. Curr Res Nutr Food Sci J. 2018;6:35‐40.
Maria Yusuf Dhariwala https://orcid.org/0000-0002-0788-3841
27. Jain PK, Das D, Das C. Prospect of herbs as hair growth potential.
Inn J Med Sci. 2017;5:25‐33.
28. Adnan M, Gul S, Batool S, et al. A review on the ethnobotany, phyto‐
REFERENCES chemistry, pharmacology and nutritional composition of Cucurbita
pepo L. J Phytopharmacol. 2017;6:133‐139.
1. Varothai S, Bergfeld WF. Androgenetic alopecia: An evidence‐
29. Lestari B, Meiyanto E. A review: the emerging nutraceutical poten‐
based treatment update. Am J Clin Dermatol. 2014;15:217‐230.
tial of pumpkin seeds. Indones J Cancer Chemoprev. 2018;9:92‐101.
2. Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of
3 0. Montesano D, Blasi F, Simonetti M, Santini A, Cossignani L.
treatment options. Drugs. 2016;76:1349‐1364.
Chemical and nutritional characterization of seed oil from Cucurbita
3. Dawber R. Aetiology and pathophysiology of hair loss. Dermatology.
maxima L. (var. Berrettina) Pumpkin. Foods. 2018;7:30.
1987;175(Suppl):23‐28.
31. Hong H, Kim C‐S, Maeng S. Effects of pumpkin seed oil and saw
4. Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia:
palmetto oil in Korean men with symptomatic benign prostatic hy‐
An update. Indian J Dermatol Venereol Leprol. 2013;79:613.
perplasia. Nutr Res Pract. 2009;3:323.
5. Thomas J. Androgenetic alopecia ‐ current status. Indian J Dermatol.
32. Cho YH, Lee SY, Jeong DW, et al. Effect of pumpkin seed oil on hair
2005;50:179‐190.
growth in men with androgenetic alopecia: a randomized, double‐
6. R. K, M. B, R. N, , et al. Current therapies of female androgenetic
blind. Placebo‐controlled trial. Evid Based Complement Alternat Med.
alopecia and use of fluridil, a novel topical antiandrogen. Scr Medica
2014;2014:1‐7.
Fac Medicae Univ Brun Masaryk. 2006;79:35‐48.
33. Al‐Sereiti MR, Abu‐Amer KM, Sen P. Pharmacology of rosemary
7. Buffoli B, Rinaldi F, Labanca M, et al. The human hair: from anatomy
(Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J
to physiology. Int J Dermatol. 2014;53:331‐341.
Exp Biol. 1999;37:124‐130.
8. Usmania BA, Kataria MK. Minoxidil emulgel for androgenic alo‐
3 4. Panahi Y, Taghizadeh M, Marzony E. Rosemary oil vs minoxidil 2%
pecia: a literature review including patents. Int J Pharm Drug Anal.
for the treatment of androgenetic alopecia: a randomized compara‐
2017;5:49‐58.
tive trial. Skinmed. 2015;13(1):15‐21.
9. Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int
35. Garavaglia J, Markoski MM, Oliveira A, et al. Grape seed oil com‐
J Womens Health. 2013;5:541‐556.
pounds: biological and chemical actions for health. Nutr Metab
10. Rossi A, Mari E, Scarnò M, et al. Comparitive effectiveness of finas‐
Insights.2016;9:59‐64.
teride vs Serenoa repens in male androgenetic alopecia: a two‐year
36. Masoudi M, Saiedi M. Anti‐cancer activity of grape seed. Pharm
study. Int J Immunopathol Pharmacol. 2012;25:1167‐1173.
Lett. 2017;9:143‐154.
11. Padois K, Cantiéni C, Bertholle V, Bardel C, Pirot F, Falson F. Solid
37. Takahashi T, Kamiya T, Yokoo Y. Proanthocyanidins from grape
lipid nanoparticles suspension versus commercial solutions for der‐
seeds promote proliferation of mouse hair follicle cells in vitro and
mal delivery of minoxidil. Int J Pharm. 2011;416:300‐304.
convert hair cycle in vivo. Acta Derm Venereol. 1998;78:428‐432.
12. Ateeq Ahmad SS. A new topical formulation of minoxidil and finas‐
38. Roshan A, Verma NK, Kumar CS, et al. Phytochemical constituent,
teride improves hair growth in men with androgenetic alopecia. J
pharmacological activities and medicinal uses through the millenia
Clin Exp Dermatol Res. 2015;06:6‐11.
of Glycyrrhiza glabra Linn: a review. Int Res J Pharm. 2012;3:45‐55.
13. Uprit S, Kumar Sahu R, Roy A, Pare A. Preparation and characteri‐
39. Kaur R, Kaur H, Dhindsa AS. Glycyrrhiza glabra: a phytopharmaco‐
zation of minoxidil loaded nanostructured lipid carrier gel for effec‐
logical review. Int J Pharm Sci Res. 2013;4:2470‐2477.
tive treatment of alopecia. Saudi Pharm J. 2013;21:379‐385.
4 0. Upadhyay S, Singh V. Potentiality of petroleum ether (60–80) °C
14. Jones MC. Treatment options for androgenetic alopecia. 2019;
extract of Glycyrrhiza glabra on androgenic alopecia. Asian J Pharm
1‐9.
Clin Res. 2013;6:52‐55.
15. Mysore V, Hair CD, Surgeon T, et al. Finasteride and sexual side
41. Kaushik R, Gupta D, Yadav R. Alopecia: herbal remedies. Int J Pharm
effects. Indian Dermatol Online J. 2019;3:62‐65.
Sci Res. 2011;2:1631‐1637.
16. Clinicaltrials. https://clinicaltrials.gov/ct2/home.
42. Saumendu DR, Raj KP, Suvakanta D, et al. Hair growth stimulating
17. Murugusundram S. Serenoa repens: DOES it have any role in the
effect and phytochemical evaluation of hydro‐alcoholic extract of
management of androgenetic alopecia? J Cutan Aesthet Surg.
Glycyrrhiza glabra. Glob J Res Med Plants Indig Med. 2014;3:40‐47.
2009;2:31‐32.
43. Kao T‐C, Wu C‐H, Yen G‐C. Bioactivity and potential health bene‐
18. Abe M, Ito Y, Suzuki A, Onoue S, Noguchi H, Yamada S. Isolation
fits of licorice. J Agric Food Chem. 2014;62:542‐553.
and pharmacological characterization of fatty acids from saw pal‐
4 4. Petkova ZY, Antova GA. Changes in the composition of pumpkin
metto extract. Anal Sci. 2009;25:553‐557.
seeds (Cucurbita moschata) during development and maturation.
19. Patel S, Sharma V, Chauhan N, et al. Hair growth: focus on herbal
Grasas Aceites. 2015;66:1‐9.
therapeutic agent. Curr Drug Discov Technol. 2015;12:21‐42.
20. Pais P, Villar A, Rull S. Determination of the potency of a novel saw
palmetto supercritical CO2 extract (SPSE) for 5alpha‐reductase iso‐
form II inhibition using a cell‐free in vitro test system. Res reports How to cite this article: Dhariwala MY, Ravikumar P. An
Urol. 2016;8:41‐49. overview of herbal alternatives in androgenetic alopecia. J
21. Mccoy J, Ziering C. Botanical extracts for the treatment of androge‐
Cosmet Dermatol. 2019;00:1–10. https://doi.org/10.1111/
netic alopecia. Int J life Sci Pharma Res. 2012;2:31‐38.
22. Chatterjee S, Agrawala SK. An effective phytotherapy. Nat Prod jocd.12930
Rad. 2003;2:302‐305.